Legislative Analysis and Public Policy Association

LAPPA is a 501(c)(3) not-for-profit corporation working in the areas of areas of public safety and health, substance use disorders, and criminal justice.

[Legislative Analysis and Public Policy Association @theLAPPA]

NIH announced that its IND application for mitragynine, the primary psychoactive compound found in kratom, has taken effect with the FDA. The IND paves the way for a phase I clinical trial to evaluate mitragynine as a potential treatment for OUD
https://t.co/ug76L81VLF

[Legislative Analysis and Public Policy Association @theLAPPA]

Findings from a nationally representative study show that nearly 1 in 4 U.S. adults (23%) either disagree or do not know that addiction is a health condition.
@AddictionPolicy
https://t.co/JIWtbn85MJ

[Legislative Analysis and Public Policy Association @theLAPPA]

The Department of Veterans Affairs announced a new clinical trial on Tuesday that will measure the safety and efficacy of MDMA-assisted therapy for treating post-traumatic stress disorder and alcohol use disorder in veterans.
https://t.co/cmj0Q7xMLH

[Legislative Analysis and Public Policy Association @theLAPPA]

LAPPA is excited to announce the publication of two new Model Acts: the "Model Involuntary Commitment for Substance Use Disorder Act" and the updated "Model Opioid Litigation Proceeds Act."

https://t.co/rKs7EVwFnE

[Legislative Analysis and Public Policy Association @theLAPPA]

About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year. It was the third straight annual drop, making it the longest decline in decades.

https://t.co/46EK1JNWHS

[Legislative Analysis and Public Policy Association @theLAPPA]

On April 25, 2026, the DEA joined 4,306 law enforcement agencies for the 30th National Prescription Drug Take Back Day. The bi-annual event collected 642,410 pounds of unneeded and expired medications at 4,417 collection sites nationwide. #TakeBackDay
https://t.co/cMh9KgMMCG

[Legislative Analysis and Public Policy Association @theLAPPA]

Next month, @samhsagov plans to remove its public, online locator tool for providers that prescribe buprenorphine and pharmacists that dispense the drug

https://t.co/ZQUbfVkpgc

[ONDCP @ONDCP]

ONDCP proudly celebrates National Prevention Week! Preventing drug use before it starts will create a healthy America. Thank you to all our #prevention partners!

[Legislative Analysis and Public Policy Association @theLAPPA]

The DEA has issued a public safety advisory stating that law enforcement and public health officials are seeing fentanyl combined with highly potent substances such as xylazine, nitazenes, cychlorphine, and medetomidine.

https://t.co/9gNblsZC60

[Legislative Analysis and Public Policy Association @theLAPPA]

Results from a clinical trial at the University of Alabama at Birmingham show that psilocybin is safe and effective in treating cocaine use disorder. @UABNews

https://t.co/4t0QL5r23u

[Legislative Analysis and Public Policy Association @theLAPPA]

Some members of Congress are urging SAMHSA to reverse course and allow funding to be used for harm-reduction tools, such as drug-testing strips to detect fentanyl.

https://t.co/C1VCC34PzQ

[Legislative Analysis and Public Policy Association @theLAPPA]

.@FACESandVOICES of Recovery has released new national survey findings showing a major shift in how Americans understand addiction, recovery, stigma, and discrimination.

https://t.co/3YeUX3PMGc

[Legislative Analysis and Public Policy Association @theLAPPA]

Recent guidance issued by SAMHSA limiting services to combat substance use is causing confusion among grantees working in harm reduction who say it is counter to other Trump administration policies.

https://t.co/p9lGJYAIhk

[Legislative Analysis and Public Policy Association @theLAPPA]

The Office of National Drug Control Policy (ONDCP) has released the 2026 National Drug Control Strategy.

https://t.co/3TOnElMxW7

[ONDCP @ONDCP]

ONDCP DRUG THREAT NOTICE: Cychlorphine, a synthetic opioid involved in at least 55 deaths, has potential to spread across Nation. Read more

[Legislative Analysis and Public Policy Association @theLAPPA]

The Trump administration is proposing wastewater testing on a national level to try to ferret out data on illegal drug use in real time, according to a draft of a new drug control strategy obtained by CBS News.

https://t.co/lXKykdGP4l

[Legislative Analysis and Public Policy Association @theLAPPA]

Methamphetamine use was involved in nearly one in six heart attacks treated at a Silicon Valley safety-net hospital, according to a new study. The patients who used meth were twice as likely to die from a heart attack as those who didn’t.
https://t.co/7Hqabh4JDD

[Legislative Analysis and Public Policy Association @theLAPPA]

SAMHSA expanded its list of prohibited harm reduction services in a pair of new guidance documents to exclude drug testing strips, including those for fentanyl and xylazine.
https://t.co/aRZjF9pAFI

[Legislative Analysis and Public Policy Association @theLAPPA]

The acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a Schedule III controlled substance. The order does not legalize marijuana under federal law, but it eases some barriers to researching cannabis.

https://t.co/PfMAHkPXta

[Legislative Analysis and Public Policy Association @theLAPPA]

A federal judge on Tuesday delayed the criminal sentencing of Purdue Pharma in order to allow victims to attend the court proceeding in person.

https://t.co/q3FNcO9dXY